SPIA
TFFP

Steward Partners Investment Advisory’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Steward Partners Investment Advisory’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4
Closed – – 3466
2022
Q3 		$0 Hold
4
– – ﹤0.01% 3422
2022
Q2 		$1K Buy
+4
New +$558 ﹤0.01% 3191

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's TFFP Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2022, closing a stake of 4 shares.

Steward Partners Investment Advisory first reported a position in TFFP in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 41 funds tracked by Wall St. Rank hold TFFP as of Q4 2022.

  • Steward Partners Investment Advisory reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 4 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2022.
  • Steward Partners Investment Advisory first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Steward Partners Investment Advisory's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.